[1/2] A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado RuvicPARIS, Dec 8 (Reuters) - France's Haute Autorite de Sante public health body advised the government not to use Valneva's (VLS.PA) VLA2001 COVID-19 vaccine as part of its wider vaccination strategy, although two rival products should be included as booster shots. The snub caused Valneva's shares to fall, with Valneva down by around 1% during the late morning trading session in Paris. "However, the HAS does not include the use of Valneva's VLA2001 vaccine in the current primary vaccination strategy", it added. Reporting by Jean-Stephane Brosse and Tassilo Hummel; Editing by Sudip Kar-GuptaOur Standards: The Thomson Reuters Trust Principles.

---